仙人掌提取物对浅Ⅱ度烫伤治疗作用的研究

目的:探讨野生仙人掌提取物对浅Ⅱ度烫伤小鼠的治疗作用。方法:建立浅Ⅱ度烫伤小鼠模型,随机分为仙人掌提取物乙醇组A1,蒸馏水组A2和混合组A3(每组又分低、中、高3个浓度),烫伤(阴性)组B,药物(阳性)组C。每天涂药1次,观察、记录创面愈合情况,分别在5d和12d各组随机取5只小鼠做病理切片,观察并记录血管、纤维细胞、成纤维细胞等的数量,进行统计学分析。结果:①混合提取物中、高浓度组愈合时间,与烫伤组相比有显著性差异(p0.05、p0.01)。②5d时不同的仙人掌提取物组与烫伤组比,血管数量、成纤维细胞占总纤维细胞的百分含量都有差异(p0.05)。结论:野生仙人掌提取物能加速烫伤创面愈合,尤其对血管和成纤维细胞有显著的促进增生作用,并加速再上皮化。     

冬瓜粗提物对小鼠紫外线晒伤皮肤的修复作用

为探讨冬瓜(Benincasa hispida)粗提物对小鼠紫外线晒伤皮肤的修复作用,建立小鼠紫外线晒伤模型。观察冬瓜粗提物对晒伤小鼠内源性血管内皮生长因子(VEGF)及碱性成纤维细胞生长因子(FGF-2)表达的影响。冬瓜提取物组(浓度均为31 mg/m L),药物组(利多卡因氯已定气雾剂),正常对照组和阴性组(生理盐水),每天2次涂药并观察创面,分别在0、1、3、7、14 d处死小鼠,取皮肤组织,做病理切片,取晒伤组织提取蛋白并检测VEGF、FGF-2的表达状况。3~7 d时,阳性对照组和实验组的VEGF和FGF-2的表达明显高于阴性对照组和正常组,且阳性组与实验组VEGF和FGF-2表达水平有显著差异。病理切片显示实验组炎性细胞和血管数量明显多于阴性对照组,且两组间差异明显。即冬瓜粗提物能提高皮肤组织的生长因子VEGF和FGF-2的表达,促进晒伤皮肤的愈合。     

肝素促进深Ⅱ度烧伤小鼠bFGF及PDGF表达的研究

目的:探讨肝素对深Ⅱ度烧伤小鼠内源性碱性成纤维生长因子(bFGF)和血小板源生长因子(PDGF)表达的影响.方法:制作小鼠深Ⅱ度烫伤模型,肝素组用3000U/mL肝素外敷伤口2min,每日2次,观察创面愈合状况,并在给药后第3天分别从肝素组(烫伤后用肝素处理)、烫伤组(烫伤后自然愈合)及对照组(未进行烫伤处理)取5只小鼠处死,提取烫伤及其周围皮肤组织的蛋白质,用Western-blotting检测bFGF和PDGF的表达状况.结果:肝素组bFGF和PDGF表达均高于烫伤组;而烫伤组的两种生长因子的表达均高于对照组.结论:烫伤后bFGF和PDGF的表达量增高,且肝素能促进深Ⅱ度烧伤内源性生长因子bFGF、PDGF的表达.     

外源性VEGF促进大鼠Ⅱ度烫伤创面中晚期愈合

目的探究Ⅱ度烫伤时外源性血管内皮生长因子(vascular endothelial growth factor,VEGF)对皮肤愈合及其对表皮干细胞(epidermal stem cells,ESCs)迁移、分化的影响方法健康Wistar大鼠随机分为VEGF组、空白对照组、阿西替尼(Axitinib,VEGF抑制剂)组。采用水浴烫伤法制备Ⅱ度烫伤模型,分别以0.2μg/ml VEGF、PBS溶液和10μg/ml阿西替尼处理各组创面,各组均治疗7d,从烫伤至创面愈合分别在第2d、8d、14d及21d测量创面愈合情况,并取创面组织作组织学检测,运用免疫组化技术检测ECSs的分布及数量。结果①创面愈合率:烫伤后21d VEGF组>对照组>阿西替尼组;②愈合速度:烫伤后1-7d空白对照组>阿西替尼组>VEGF组,其后VEGF组愈合速度逐渐加快,第14d开始愈合速度表现为VEGF组>空白对照组>阿西替尼组;③组织学变化:烫伤后8-21d,VEGF组表皮细胞增殖明显,表皮修复和毛囊再生迅速,均早于空白对照组及阿西替尼组。④ECSs阳性细胞率变化:烫伤后第8-14dVEGF组ECSs阳性细胞率明显高于空白对照组和阿西替尼。结论Ⅱ度烫伤时,外源性VEGF在愈合中晚期加快愈合速度使愈合时间明显缩短,并且促进毛囊汗腺的再生使修复后的创面在外观、功能与正常皮肤相近,有助于提高全层皮肤创面的愈合质量。     

重组融合多肽hEGF-AWRK6的纯化及对小鼠烫伤感染创面愈合的影响

旨在研究重组融合多肽hEGF-AWRK6(EK)对烫伤模型小鼠感染创面的治疗功效。采用大肠杆菌表达系统表达、纯化融合多肽EK,抑菌实验检测EK抑菌活性;构建小鼠II度烫伤和铜绿假单胞菌感染模型,实验组创面滴注EK(30 mg/L),以PBS、庆大霉素(30 mg/L)、烫伤膏(10 mg/L)为对照,计算烫伤后创面愈合率及菌落数;伤后10 d,取各组小鼠的伤口及周边皮肤进行HE染色及胶原蛋白的Western blotting检测,分析创面病理组织结构。实验结果纯化得到了具有抑菌活性的重组表达融合肽EK;伤后6 d始,EK组小鼠创面菌落数少于对照组,差异极显著(P0.01);EK组小鼠烫伤愈合率显著高于PBS对照组(P0.01);与对照组相比,EK组小鼠创面真皮层细胞排列规则,再上皮化较快,毛囊生长较多,Ⅰ型胶原蛋白表达显著增加。结果表明EK具有抑制小鼠烫伤创面感染、促创面愈合功效,具有开发成为治疗烧伤药物的潜力。     

獾油促进深Ⅱ度烫伤小鼠创面愈合作用的研究

目的:检测獾油对小鼠深Ⅱ度烫伤创面愈合的促进作用.方法:制备小鼠深Ⅱ度烫伤模型,分为烫伤对照组(A组)、植物油治疗组(B组)和獾油治疗组(C组).创面依次用生理盐水纱布、植物油纱布、獾油纱布覆盖.无菌纱布包扎固定,每日换药一次.于伤后7天、10天、15天按照Nagelschmidt法观察并记录创面愈合面积,计算创面愈合率;取创面组织,制成石蜡切片,观察病理及组织形态学变化.结果:獾油能加速烫伤创面的再上皮化,促进创面的愈合;提高烫伤组织细胞的增殖活性;促进烫伤创面表皮干细胞的增殖分化.结论:獾油对深Ⅱ度烫伤创面愈合有促进作用     

在烫伤条件下VEGF对大鼠皮肤eNOS基因表达的影响

目的:探讨大鼠烫伤愈合过程中VEGF对皮肤组织eNOS基因表达的影响。方法:采用了大鼠深II度烫伤模型,分别以VEGF和阿西替尼(VEGF抑制剂)干预,观察大鼠烫伤后愈合过程的组织学变化,PCR检测创面eNOS基因的表达。结果:肉眼观察VEGF组大鼠创面最早愈合,对照组大鼠愈合速度其次,阿西替尼组创面愈合最晚;HE染色结果显示伤后第2、8、21天VEGF组炎性细胞浸润程度、新生毛细血管数量均高于对照组和阿西替尼组,PCR结果显示烫伤后第2、8天VEGF组的eNOS基因的表达明显上调,且同时间点与对照组比较有统计学意义(P0.05)。结论:VEGF可诱导烫伤创面eNOS基因的表达,增加血管生成重要因子NO的生成,有利于创面愈合。     

烧烫伤创面感染的小鼠模型构建

目的探讨一种简单、稳定的烧烫伤创面感染的小鼠模型构建方法,以便进行相关烧烫伤创面修复研究。方法取30只BALB/c小鼠,采用自制木质烫伤板,沸水浴法烫取直径8 mm的圆形创面,烫伤时间分别为5 s、10 s、15 s。伤后48 h,取创面组织进行HE染色观察,筛选最佳创面烫伤时间。另取72只小鼠制成深Ⅱ度烫伤创面,采用擦刮法分别接种20μL菌浓度为1×106、l×107、1×108CFU/mL金黄色葡萄球菌标准菌株ATCC 25923的菌液。接种细菌后72 h,取创面组织HE染色观察创面炎症反应情况,并测定3、7、14 d的皮肤菌负荷,筛选最佳的细菌接种浓度。最后,按最佳条件建模后,观察创面的完全愈合时间以及创面愈中、愈后的组织学变化,以确定此创面感染模型是否建立成功。结果组织学结果表明,10 s为深Ⅱ度创面的理想致伤时间,最佳接种菌浓度为l×108CFU/mL,此时期,14 d内菌负荷均高于l×105CFU/g。该模型的创面愈合时间(21±0.95 d)较正常创面愈合时间(15.92±0.34 d)明显延长(P<0.01),炎性反应明显,愈后不佳。结论烧烫伤创面感染的小鼠模型构建成功,可作为感染创面防治研究的实验动物模型。     

肝癌疼痛与血浆VEGF、BDNF、FGF-2水平的相关性研究

目的:研究肝癌疼痛与血浆血管内皮生长因子(VEGF)、脑源性神经营养因子(BDNF)、纤维细胞生长因子-2(FGF-2)水平的相关性。方法:选择我院2018年10月～2019年7月收治的30例肝癌疼痛患者作为研究对象,依据疼痛程度分为4例轻度疼痛组、19例中度疼痛组、7例重度疼痛组,同期纳入30例肝癌无痛患者和30例健康对照组,比较各组血浆VEGF、BDNF和FGF-2水平,并分析肝癌疼痛患者血浆VEGF、BDNF和FGF-2水平和数字评分法(NRS)评分的相关性。结果:肝癌疼痛组血浆VEGF、BDNF、FGF-2水平显著高于肝癌无痛组及对照组(P0.05)。重度疼痛组血浆VEGF、BDNF、FGF-2水平显著高于中度疼痛组及轻度疼痛组(P0.05)。治疗后,肝癌疼痛患者血浆VEGF、BDNF、FGF-2水平显著低于治疗前(P0.05)。肝癌疼痛患者血浆VEGF、BDNF、FGF-2水平和NRS评分呈显著正相关(r值分别为0.619、0.571、0.563,P值均0.001)。结论:肝癌疼痛患者血浆VEGF、BDNF和FGF-2水平较肝癌无痛者明显上升,且和疼痛程度显著相关。     

马桑水提取物对大鼠深Ⅱ度烧伤创面微循环和氧化应激的影响

目的：探索马桑水提取物（CSME）对大鼠深Ⅱ度烧伤创面微循环和氧化应激的影响。方法：随机将180只SD大鼠分成6组（n=30）：对照组（生理盐水组,NS）、凡士林组（WPL）、磺胺嘧啶银组（SSD）、马桑提取物组（低剂量组（CSME-L）、中剂量组（CSME-M）和高剂量组（CSME-H）。麻醉后用烫伤仪烫伤脱毛区（病理结果证实深Ⅱ度烫伤）,伤后创面分别涂擦NS、WPL、SSD和不同浓度的CSME烧伤软膏。于伤后48 h、7 d、14 d、21 d计算创面愈合率（HR）,检测创面微血管（MVD）、创面组织含水量（TM）、血管内皮生长因子（VEGF）、丙二醛（MDA）、超氧化物歧化酶（SOD）、羟脯氨酸（HYP）,进行创面组织学观察。结果：CSME各组的HR呈剂量依赖性大于NS和WPL （P<0.05）;在21 d,其创面组织血管管径、数量、分布及TM呈剂量依赖性少于其他各组（P<0.05）,伤后7 d、14 d,CSME各组呈现剂量依赖性高于NS、WPL和SSD （P<0.05）,而伤后21 d呈剂量依赖性低于NS、WPL和SSD （P<0.05）;CSME的SOD活性、HYP、NO和ET含量呈剂量依赖性高于其他各组（P<0.05）,而MDA活性呈剂量依赖性弱于其他各组（P<0.05）,CSME呈剂量依赖性缩短创面修复时间,瘢痕少于其他各组。结论：CSME具有早期减轻烧伤创面组织水肿、促进创面收缩、加快创面结痂以及促进肉芽组织增生,有利于创面愈合;后期则抑制创面肉芽组织增生,防止瘢痕过度增生。其机制与创面微循环、氧化应激、NO和VEGF的调控有关。     

Developmental regulations of Perp in mice molar morphogenesis

Angiogenesis, a complex biologic process, is regulated by a large number of angiogenic factors, including vascular endothelial growth factor (VEGF) and fibroblast growth factor-2 (FGF-2). Whether Bone morphogenetic proteins-2 (BMP-2), the osteoinductive factor, could significantly reinforce the effect of VEGF and FGF-2 on angiogenesis has not been studied in detail. To study the positive effects of multiple growth factors on angiogenesis, HUVECs were treated with BMP-2, VEGF, or FGF-2 singly and in binary and ternary combinations. This study further investigates the optimal timing of the ternary combination of BMP-2, VEGF and FGF-2 for angiogenesis in the chorioallantoic membrane (FGF-2 CAM). Results of single applications of BMP-2, VEGF, or FGF-2 suggested that HUVECs angiogenesis could be promoted in a dose-dependent manner and that the optimal concentration of BMP, VEGF and FGF-2 was 10, 50 and 1 ng/mL, respectively. These results indicated that the angiogenic activity of VEGF and FGF-2 was amplified by combining with BMP-2. The ternary combination of BMP-2, VEGF and FGF-2 exhibited a positive and synergistic effect on HUVECs angiogenesis, with the lower concentrations of each factor (1 ng/mL of BMP-2, 25 ng/mL of VEGF and 0.1 ng/mL of FGF-2) being sufficient to show synergistic promotion. When VEGF and FGF-2 were added in the initial activation stage and BMP-2 was added in the maturation stage, both HUVECs angiogenesis in vitro and CAM angiogenesis in vivo could be enhanced more effectively. These results could provide a basis for the controlled release systems capable of delivering multiple factors sequentially to promote angiogenesis in tissue engineering.     

Cyclic mechanical stretch induces VEGF and FGF-2 expression in pulmonary vascular smooth muscle cells

Vascular endothelial growth factor (VEGF) and basic (b) fibroblast growth factor (FGF-2/bFGF) are involved in vascular development and angiogenesis. Pulmonary artery smooth muscle cells express VEGF and FGF-2 and are subjected to mechanical forces during pulsatile blood flow. The effect of stretch on growth factor expression in these cells is not well characterized. We investigated the effect of cyclic stretch on the expression of VEGF and FGF-2 in ovine pulmonary artery smooth muscle cells. Primary confluent cells from 6-wk-old lambs were cultured on flexible silicon membranes and subjected to cyclic biaxial stretch (1 Hz; 5-25% stretch; 4-48 h). Nonstretched cells served as controls. Expression of VEGF and FGF-2 was determined by Northern blot analysis. Cyclic stretch induced expression of both VEGF and FGF-2 mRNA in a time- and amplitude-dependent manner. Maximum expression was found at 24 h and 15% stretch (VEGF: 1.8-fold; FGF-2: 1.9-fold). These results demonstrate that mechanical stretch regulates VEGF and FGF-2 gene expression, which could play a role in pulmonary vascular development or in postnatal pulmonary artery function or disease.     

Fibroblast growth factor-2 and vascular endothelial growth factor expression in the ileocecal region of quail (Coturnix coturnix japonica)

Abstract

We undertook this study to immunolocalize in quail vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF-2) in the ileocecal region, which is a significant entry point for intestinal immunity. Diffuse cytoplasmic reaction for FGF-2 and VEGF was observed in the epithelial cells of the distal ileum and proximal cecal mucosa. VEGF immunoreactive cells, which give strong intracytoplasmic immunoreaction, were observed in the lamina propria of both intestinal parts. FGF-2 immunoreactive cells were seen in the lamina propria and germinative centers of lymph follicles in the cecum mucosa. Expressions of FGF-2 and VEGF in healthy quail intestines indicate that these factors have physiological roles in quail.     

Anti-angiogenic Property of Edible Berries

Recent studies show that edible berries may have potent chemopreventive properties. Anti-angiogenic approaches to prevent and treat cancer represent a priority area in investigative tumor biology. Vascular endothelial growth factor (VEGF) plays a crucial role for the vascularization of tumors. The vasculature in adult skin remains normally quiescent. However, skin retains the capacity for brisk initiation of angiogenesis during inflammatory skin diseases such as psoriasis and skin cancers. We sought to test the effects of multiple berry extracts on inducible VEGF expression by human HaCaT keratinocytes. Six berry extracts (wild blueberry, bilberry, cranberry, elderberry, raspberry seed, and strawberry) and a grape seed proanthocyanidin extract (GSPE) were studied. The extracts and uptake of their constituents by HaCaT were studied using a multi-channel HPLC-CoulArray approach. Antioxidant activity of the extracts was determined by ORAC. Cranberry, elderberry and raspberry seed samples were observed to possess comparable ORAC values. The antioxidant capacity of these samples was significantly lower than that of the other samples studied. The ORAC values of strawberry powder and GSPE were higher than cranberry, elderberry or raspberry seed but significantly lower than the other samples studied. Wild bilberry and blueberry extracts possessed the highest ORAC values. Each of the berry samples studied significantly inhibited both H 2 O 2 as well as TNF &#102 induced VEGF expression by the human keratinocytes. This effect was not shared by other antioxidants such as &#102 -tocopherol or GSPE but was commonly shared by pure flavonoids. Matrigel assay using human dermal microvascular endothelial cells showed that edible berries impair angiogenesis.     

Response to thalidomide in multiple myeloma: impact of angiogenic factors

Thalidomide has antiangiogenic and immunomodulatory effects, mediated by several cytokines such as vascular endothelial growth factor (VEGF), fibroblastic growth factor (FGF-2), hepatocyte growth factor (HGF), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha). Although extramedullary plasmacytomas (EMP) have a high vascularization, the response of these patients to thalidomide is controversial. Thirty-eight patients with refractory/relapsed MM were treated with thalidomide. Eleven patients had EMP when therapy was initiated. Serum specimens were obtained in patients before treatment was started and at the time of maximum response in responding patients or at thalidomide discontinuation in non-responders. Serum levels of VEGF, HGF and FGF-2 were determined in 18 patients whereas IL-6 and TNF-alpha were measured in 19 patients. Sixteen of the 38 patients (42%) responded to thalidomide. The response rate was significantly higher in patients without EMP (59% vs 0%, p = 0.0006 ). VEGF serum levels were significantly higher in responding patients. In contrast, baseline serum levels of HGF were significantly lower in responders. Neither VEGF nor HGF serum levels showed correlation with the presence of EMP. Baseline TNF-alpha serum levels were significantly lower in responding patients and in those without EMP. The serum levels of FGF-2 and IL-6 did not correlate with response to treatment or presence of EMP.     

Vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) expression during induced luteolysis in the bovine corpus luteum

Angiogenic factors, like vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF), and their receptors, are strongly regulated during the development of bovine corpus luteum (CL). The aim of this study was to investigate real-time changes of these factors in luteal tissue of cows (n = 4-5 per group) in the mid-luteal phase (day 8-12) after intramuscular injection of the PGF2alpha-analog Cloprostenol. Before (control) and 2, 4, 12, 48, and 64 hr after prostaglandin (PG) injection, CL were collected by transvaginal ovariectomy. RT-PCR for VEGF, VEGF-receptor type 1 (VEGF-R1), VEGF-R2, acidic FGF (FGF-1), basic FGF (FGF-2), and FGF-receptor (FGF-R) was performed. Additionally, the protein concentration for VEGF was determined. The mRNA expression of VEGF and its two receptors (VEGF-R1 and -R2) was significantly downregulated during structural luteolysis (after 12 hr). VEGF protein concentration already significantly declined 2 hr after PGF2alpha. Surprisingly FGF-1 and FGF-2 were significantly and maximally upregulated during functional luteolysis (until 12 hr). Furthermore, FGF-R mRNA was significantly upregulated at 2 hr after PGF2alpha, when compared with the control group. During structural luteolysis, the expression of FGFs and their receptors was not significantly different from control, except FGF-2 mRNA, which was downregulated at 64 hr. We conclude that the cessation of VEGF-support for the CL plays a role during structural luteolysis, whereas FGFs seem to have a major impact on functional luteolysis. The possible role of these growth factors could be a transient counter-regulation of luteolysis, but also an involvement in preventing inflammatory reactions during luteal regression.     

Anti-angiogenic property of edible berries

Recent studies show that edible berries may have potent chemopreventive properties. Anti-angiogenic approaches to prevent and treat cancer represent a priority area in investigative tumor biology. Vascular endothelial growth factor (VEGF) plays a crucial role for the vascularization of tumors. The vasculature in adult skin remains normally quiescent. However, skin retains the capacity for brisk initiation of angiogenesis during inflammatory skin diseases such as psoriasis and skin cancers. We sought to test the effects of multiple berry extracts on inducible VEGF expression by human HaCaT keratinocytes. Six berry extracts (wild blueberry, bilberry, cranberry, elderberry, raspberry seed, and strawberry) and a grape seed proanthocyanidin extract (GSPE) were studied. The extracts and uptake of their constituents by HaCaT were studied using a multi-channel HPLC-CoulArray approach. Antioxidant activity of the extracts was determined by ORAC. Cranberry, elderberry and raspberry seed samples were observed to possess comparable ORAC values. The antioxidant capacity of these samples was significantly lower than that of the other samples studied. The ORAC values of strawberry powder and GSPE were higher than cranberry, elderberry or raspberry seed but significantly lower than the other samples studied. Wild bilberry and blueberry extracts possessed the highest ORAC values. Each of the berry samples studied significantly inhibited both H2O2 as well as TNF alpha induced VEGF expression by the human keratinocytes. This effect was not shared by other antioxidants such as alpha-tocopherol or GSPE but was commonly shared by pure flavonoids. Matrigel assay using human dermal microvascular endothelial cells showed that edible berries impair angiogenesis.     

AMP-activated protein kinase positively regulates FGF-2-stimulated VEGF synthesis in osteoblasts

AMP-activated protein kinase (AMPK) is recognized as a regulator of energy homeostasis. We have previously reported that basic fibroblast growth factor (FGF-2) stimulates vascular endothelial growth factor (VEGF) release through the activation of p44/p42 mitogen-activated protein (MAP) kinase and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in osteoblast-like MC3T3-E1 cells. In the present study, we investigated the involvement of AMPK in FGF-2-stimulated VEGF release in these cells. FGF-2 time-dependently induced the phosphorylation of AMPK α-subunit (Thr-172). Compound C, an AMPK inhibitor, which suppressed the FGF-2-induced phosphorylation of AMPK, significantly inhibited the VEGF release stimulated by FGF-2. The AMPK inhibitor also reduced the mRNA expression of VEGF induced by FGF-2. The FGF-2-induced phosphorylation of both p44/p42 MAP kinase and SAPK/JNK was attenuated by compound C. These results strongly suggest that AMPK positively regulates the FGF-2-stimulated VEGF synthesis via p44/p42 MAP kinase and SAPK/JNK in osteoblasts.     

Up-regulation by zinc of FGF-2-induced VEGF release through enhancing p44/p42 MAP kinase activation in osteoblasts

We previously reported that basic fibroblast growth factor (FGF-2) activates stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) and p44/p42 mitogen-activated protein (MAP) kinase resulting in the stimulation of vascular endothelial growth factor (VEGF) release in osteoblast-like MC3T3-E1 cells. In the present study, we investigated whether zinc affects the VEGF release by FGF-2 in MC3T3-E1 cells. The FGF-2-induced VEGF release was significantly enhanced by ZnSO(4) but not Na(2)SO(4). The enhancing effect of ZnSO(4) was dose-dependent between 1 and 100 muM. ZnSO(4) markedly enhanced the FGF-2-induced phosphorylation of p44/p42 MAP kinase while having little effect on the SAPK/JNK phosphorylation. PD98059 significantly reduced the amplification by ZnSO(4) of the FGF-2-stimulated VEGF release. Taken together, our findings strongly suggest that zinc enhances FGF-2-stimulated VEGF release resulting from up-regulating activation of p44/p42 MAP kinase in osteoblasts.